• 1
    The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Bethesda , MD : National Institutes of Health; National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program; November 1997. NIH Publication 98-4080.
  • 2
    Burt VL, Whelton P, Roccella EJ, et al. Prevalence of hypertension in the US adult population. Results from the third National Health and Nutrition Examination Survey, 1988–1991. Hypertension. 1995;25:305311.
  • 3
    Frohlich ED, Messerli FH, Dunn FG, et al. Greater renal vascular involvement in the black patient with essential hypertension: a comparison of systemic and renal hemodynamics in black and white patients. Mineral Electrolyte Metab. 1984;10:173177.
  • 4
    Saunders E. Hypertension in blacks. Med Clin North Am. 1987;71:10131029.
  • 5
    Clark LT. Improving compliance and increasing control of hypertension: needs of special hypertensive populations. Am Heart J. 1991;121:664669.
  • 6
    Weir MR, Saunders E, for the Trandolapril Multicenter Study Group. Renin status does not predict the anti-hypertensive response to angiotensin-converting enzyme inhibition in African Americans. J Hum Hypertens. 1998;12:189194.
  • 7
    D'Agostino RB Sr, Grundy S, Sullivan LM, et al. for the CHD Risk Prediction Group. Validation of the Framingham coronary heart disease prediction scores. Results of a Multiple Ethnic Groups Investigation. JAMA. 2001;286:180187.
  • 8
    American Heart Association. 2003 Heart Disease and Stroke Statistics-Update. Dallas , TX : American Heart Association; 2002.
  • 9
    Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the Hypertension Detection and Follow-up Program: mortality by race, sex and blood pressure level. A further analysis. J Commun Health. 1984;9:314327.
  • 10
    Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med. 2001;345:479486.
  • 11
    Clark LT, Emerole O. Coronary heart disease in African Americans: primary and secondary prevention. Cleve Clin J Med. 1995; 62:285292.
  • 12
    Clark LT, Ferdinand KC, Flack JM, et al. Coronary heart disease in African Americans. Heart Disease. 2001;3:97108.
  • 13
    National Center for Health Statistics (NCHS). Fast stats. Available at: http:www.cdc.govnchsfastats. Accessed July 30, 2002.
  • 14
    Centers for Disease Control and Prevention. Diabetes: disabling, deadly, and on the rise. Available at: www.cdc.govdiabetespubsglance.htm. Accessed October 25, 2002.
  • 15
    Geiss LS, Rolka DB, Engelgau MM. Elevated blood pressure among US adults with diabetes, 1988–1994. Am J Prev Med. 2002;22:4248.
  • 16
    Gu K, Cowie CC, Harris MI. Diabetes and decline in heart disease mortality in US adults. JAMA. 1999;281:12911297.
  • 17
    Multiple Risk Factor Intervention Trial Research Group. Multiple risk factor intervention trial. Risk factor changes and mortality results. JAMA. 1982;248:14651477.
  • 18
    The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA. 1984;251:365374.
  • 19
    Gidding SS, Liu K, Bild DE, et al. Prevalence and identification of abnormal lipoprotein levels in a biracial population aged 23 to 35 years (the CARDIA study). The Coronary Risk Development in Young Adults study. Am J Cardiol. 1996;78: 304308.
  • 20
    Gillum RF. The epidemiology of cardiovascular disease in black Americans [editorial]. N Engl J Med. 1996;335:15971598.
  • 21
    Prisant LM, Thurmond C, Robinson VJ. Treating hyperlipidemia in African Americans. Ethnicity Dis. 2000;10:334342.
  • 22
    Must A, Spadano J, Coakley EH, et al. The disease burden associated with overweight and obesity. JAMA. 1999;282: 15231529.
  • 23
    Winkleby MA, Kraemer HC, Ahn DK, et al. Ethnic and socioeconomic difference in cardiovascular disease risk factors: findings for women from the Third National Health and Nutrition Examination Survey, 1988–1994. JAMA. 1998;280:356362.
  • 24
    Crespo C, Keteyian S, Heath G, et al. Leisure-time physical activity among US adults: results from The Third National Health and Nutrition Examination Survey. Arch Intern Med. 1996;156:9398.
  • 25
    Burke GL, Savage PJ, Manolio TA, et al. Correlates of obesity in young black and white women: the CARDIA Study. Am J Public Health. 1992;82:16211625.
  • 26
    Jamerson K. The impact of ethnicity on response to antihypertensive therapy. Am J Med. 1996;101(Suppl 3A):22S32S.
  • 27
    Thomas J, Thomas DJ, Pearson T, et al. Cardiovascular disease in African American and white physicians: the Meharry cohort and Meharry-Hopkins cohort studies. J Health Care Poor Underserved. 1997;8:270284.
  • 28
    Cooper R, Cutler J, Desvigne-Nickens P, et al. Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States. Findings of the National Conference on Cardiovascular Disease Prevention. Circulation. 2000;102:31373147.
  • 29
    Lackland DT, Egan BM, Jones PJ. Impact of nativity and race on “stroke belt” mortality. Hypertension. 1999;34:5762.
  • 30
    Flack JM, Mensah GA, Ferrario CM. Using angiotensin converting enzyme inhibitors in African-American hypertensives: a new approach to treating hypertension and preventing targetorgan damage. Curr Med Res Opin. 2000;16:6679.
  • 31
    Rahman M, Douglas JG, Wright JT. Pathophysiology and treatment implications of hypertension in the African-American population. Endocrinol Metab Clin North Am. 1997;26:125144.
  • 32
    Flack JM, Gardin JM, Yunis C, et al. , for the CARDIA Research Group. Static and pulsatile blood pressure correlates of left ventricular structure and function in black and white young adults: the CARDIA study. Am Heart J. 1999;138:856864.
  • 33
    Moser M, Basile J, Miller ER, et al. Roundtable discussion: hypertension, renal disease, and diabetes. J Clin Hypertens. 2002;4:113119.
  • 34
    Mailloux LU, Levey AS. Hypertension in patients with chronic renal disease. Am J Kidney Dis. 1998;32(Suppl 3):S120S141.
  • 35
    Klag MJ, Whelton PK, Randall BL, et al. End-stage renal disease in African-American and white men; 16-year MRFIT findings. JAMA. 1997;277:12931298.
  • 36
    Flack JM, Neaton JD, Daniels B, et al. Ethnicity and renal disease: lessons from the Multiple Risk Factor Intervention Trial and the Treatment of Mild Hypertension Study. Am J Kidney Dis. 1993;21(Suppl 1):3140.
  • 37
    Agodoa L. African American Study of Kidney Disease and Hypertension (AASK)-clinical trial update. Ethnicity Dis. 1998;8:249253.
  • 38
    United States Renal Data System (USRDS). Incidence and prevalence of ESRD. In: USRDS 1999 Annual Data Report. Minneapolis , MN : United States Renal Data System; 1999:2538.
  • 39
    Henry RM, Kostense PJ, Bos G, et al. Mild renal insufficiency is associated with increased cardiovascular mortality: the Hoorn Study. Kidney Int. 2002;62:14021407.
  • 40
    Muntner P, He J, Hamm L, et al. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol. 2002;13:745753.
  • 41
    Earle KA, Mehrotra S, Dalton RN, et al. Defective nitric oxide production and functional renal reserve in patients with type 2 diabetes who have microalbuminuria of African and Asian compared to white origin. J Am Soc Nephrol. 2001;12:21252130.
  • 42
    Hall JE, Brands MW, Henegar JR, et al. Abnormal kidney function as a cause and a consequence of obesity hypertension. Clin Exp Pharmacol Physiol. 1998;25:5864.
  • 43
    Briganti EM, Branley P, Chadban SJ, et al. Smoking is associated with renal impairment and proteinuria in the normal population: the AusDiab kidney study. Australian Diabetes, Obesity and Lifestyle Study. Am J Kidney Dis. 2002;40:704712.